Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer - Related Studies

Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer

This study has been completed.

Study NCT00035152. Last updated on June 27, 2008. Information provided by Bristol-Myers Squibb

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Carcinoma, Non-Small-Cell Lung

2	Additional conditions recognized in this trial
		Carcinoma

3	More general conditions related to this trial
		Lung Diseases
		Lung Neoplasms
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Respiratory Tract Diseases
		Respiratory Tract Neoplasms
		Thoracic Neoplasms

4	Interventions listed in this trial
		Paclitaxel and carboplatin

5	Additional drug interventions recognized in this trial
		Carboplatin
		Paclitaxel

6	More general drug interventions related to this trial
		Antimitotic Agents
		Antineoplastic Agents
		Antineoplastic Agents, Phytogenic
		Mitosis Modulators
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses
		Tubulin Modulators

7	Sponsors listed in this trial
		Bristol-Myers Squibb